Hopfinger, G <br/><br/>
Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma.  [electronic resource] 

 -  European journal of haematology  Oct 1995 
 - 223-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0902-4441 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0609.1995.tb00261.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Recurrence<br/>Retrospective Studies<br/>Salvage Therapy<br/>Survival Rate<br/>Time Factors<br/>Transplantation, Autologous